Review Article
Prognostic Role of Elevated Myeloperoxidase in Patients with Acute Coronary Syndrome: A Systemic Review and Meta-Analysis
Table 2
Sample collection methods and time of sample collection in relation to onset of chest pain/hospital admission of the included studies.
| | Apple et al. [31] | Baldus et al. [34] | Brugger-Andersen et al. [30] | Cavusoglu et al. [38] | Chang et al. [28] | Eggers et al. [9] | Kaya et al. [10] | Koch et al. [26] | Mocatta et al. [27] | Morrow et al. [39] | Rahman et al. [32] | Scirica et al. [29] |
| | Sample collection method | Heparin-containing tubes | NR | Citrate-anticoagulated tubes | NR | NR | EDTA-anticoagulated tubes | NR | EDTA-anticoagulated tubes | EDTA-anticoagulated tubes | Citrate-anticoagulated tubes | NR | EDTA-anticoagulated tubes | | Time of sample collection | Within 3.1 hours from the onset of symptoms | Within 8.7 hours from the onset of symptoms | Within 4-6 days from the onset of symptoms | ≥12 hours after hospital admission | At hospital admission | After 0.8 hour from hospital admission | Within 6 hours of the onset of symptoms | After 26.1 hours from hospital admission | From 24 to 96 hours after hospital admission | NR | NR | NR |
|
|
Oemrawsingh et al. is a longer follow-up report of Baldus et al.’s study; the study’s subjects received heparin before blood samples were withdrawn. |
